Hypermarcas (OTCMKTS:HYPMY) Shares Gap Up – What’s Next?

Hypermarcas (OTCMKTS:HYPMYGet Free Report) gapped up prior to trading on Monday . The stock had previously closed at $3.96, but opened at $4.1125. Hypermarcas shares last traded at $4.1125, with a volume of 218 shares trading hands.

Wall Street Analyst Weigh In

Separately, Zacks Research raised shares of Hypermarcas to a “hold” rating in a research note on Wednesday, April 29th. One equities research analyst has rated the stock with a Strong Buy rating and one has issued a Hold rating to the stock. According to MarketBeat, Hypermarcas has a consensus rating of “Buy”.

View Our Latest Stock Analysis on Hypermarcas

Hypermarcas Stock Up 2.4%

The company’s fifty day simple moving average is $4.25 and its two-hundred day simple moving average is $4.39. The company has a market capitalization of $2.90 billion, a price-to-earnings ratio of 8.57 and a beta of 0.71.

Hypermarcas (OTCMKTS:HYPMYGet Free Report) last announced its quarterly earnings results on Wednesday, April 29th. The company reported $0.10 earnings per share (EPS) for the quarter. Hypermarcas had a net margin of 19.41% and a return on equity of 14.08%. The company had revenue of $383.13 million during the quarter. Equities research analysts expect that Hypermarcas will post 0.53 earnings per share for the current year.

Hypermarcas Company Profile

(Get Free Report)

Hypermarcas SA is a Brazil-based consumer health and pharmaceutical company whose shares trade over the counter in the United States under the symbol HYPMY. Founded in the early 2000s and headquartered in Rio de Janeiro, the company operates as a holding group for a broad portfolio of branded products in the healthcare and personal care sectors.

Through its various subsidiaries, Hypermarcas develops, manufactures and markets prescription and over-the-counter medications, alongside personal care, baby care, home care and nutritional supplement products.

Featured Stories

Receive News & Ratings for Hypermarcas Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Hypermarcas and related companies with MarketBeat.com's FREE daily email newsletter.